Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rawiwan Wongnak"'
Autor:
Rawiwan Wongnak, Subbaian Brindha, Mami Oba, Takahiro Yoshizue, Md. Din Islam, M. Monirul Islam, Hitoshi Takemae, Tetsuya Mizutani, Yutaka Kuroda
Publikováno v:
Molecules, Vol 29, Iss 11, p 2676 (2024)
The Omicron BA.5 variant of SARS-CoV-2 is known for its high transmissibility and its capacity to evade immunity provided by vaccine protection against the (original) Wuhan strain. In our prior research, we successfully produced the receptor-binding
Externí odkaz:
https://doaj.org/article/db540d4fcff048e2bb9197300c2132bb
Autor:
Rawiwan Wongnak, Subbaian Brindha, Takahiro Yoshizue, Sawaros Onchaiya, Kenji Mizutani, Yutaka Kuroda
Publikováno v:
Biophysics and Physicobiology, Vol 20 (2023)
Low-cost bacterial production of the receptor binding domain (RBD) of the SARS-CoV-2 Omicron spike protein holds significant potential in expediting the development of therapeutics against COVID-19. However, RBD contains eight cysteines forming four
Externí odkaz:
https://doaj.org/article/819f364e4fc448989118ac605516667c
Autor:
Kuroda, Takahiro Yoshizue, Subbaian Brindha, Rawiwan Wongnak, Hitoshi Takemae, Mami Oba, Tetsuya Mizutani, Yutaka
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10583
E. coli-expressed proteins could provide a rapid, cost-effective, and safe antigen for subunit vaccines, provided we can produce them in a properly folded form inducing neutralizing antibodies. Here, we use an E. coli-expressed SARS-CoV-2 receptor-bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::33dda14d46abba9a3315a8cba2833c81
Autor:
Subbaian, Brindha, Takahiro, Yoshizue, Rawiwan, Wongnak, Hitoshi, Takemae, Mami, Oba, Tetsuya, Mizutani, Yutaka, Kuroda
Publikováno v:
International journal of molecular sciences. 23(24)
A large-scale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a81ecc3efa1b8040f9043d788e90f63
https://pubmed.ncbi.nlm.nih.gov/36555383
https://pubmed.ncbi.nlm.nih.gov/36555383
Autor:
Subbaian Brindha, Takahiro Yoshizue, Rawiwan Wongnak, Hitoshi Takemae, Mami Oba, Tetsuya Mizutani, Yutaka Kuroda
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15744
A large-scale Escherichia coli (E. coli) production of the receptor-binding domain (RBD) of the SARS-CoV-2 could yield a versatile and low-cost antigen for a subunit vaccine. Appropriately folded antigens can potentially elicit the production of neut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bba6b2e7319178db6361de5d753cea5
https://doi.org/10.3390/ijms232415744
https://doi.org/10.3390/ijms232415744